Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

New genetic variants of genes MMR in a Spanish family with Lynch syndrome.

Martín Ruiz JL, Alvarez-Cubero MJ, Fernandez Rosado J, Martinez Espín E, Entrala Bernal C.

Int J Colorectal Dis. 2013 Oct;28(10):1451-2. doi: 10.1007/s00384-012-1615-3. Epub 2012 Dec 8. No abstract available.

PMID:
23224667
2.

Familial colorectal cancer: eleven years of data from a registry program in Switzerland.

Kovac M, Laczko E, Haider R, Jiricny J, Mueller H, Heinimann K, Marra G.

Fam Cancer. 2011 Sep;10(3):605-16. doi: 10.1007/s10689-011-9458-6.

PMID:
21671081
3.

Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians.

Sijmons RH, Greenblatt MS, Genuardi M.

Fam Cancer. 2013 Jun;12(2):181-7. doi: 10.1007/s10689-013-9629-8.

PMID:
23525798
4.

Genetic modifiers of cancer risk in Lynch syndrome: a review.

Talseth-Palmer BA, Wijnen JT, Grice DM, Scott RJ.

Fam Cancer. 2013 Jun;12(2):207-16. doi: 10.1007/s10689-013-9614-2. Review.

5.

Prediction of Lynch syndrome in consecutive patients with colorectal cancer.

Green RC, Parfrey PS, Woods MO, Younghusband HB.

J Natl Cancer Inst. 2009 Mar 4;101(5):331-40. doi: 10.1093/jnci/djn499. Epub 2009 Feb 24.

PMID:
19244167
6.

Genotype-phenotype correlation in MMR mutation-positive families with Lynch syndrome.

Pérez-Cabornero L, Infante M, Velasco E, Lastra E, Miner C, Durán M.

Int J Colorectal Dis. 2013 Sep;28(9):1195-201. doi: 10.1007/s00384-013-1685-x. Epub 2013 Apr 16.

PMID:
23588873
7.

A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance-functional analysis reveals the pathogenic one.

Kantelinen J, Hansen TV, Kansikas M, Krogh LN, Korhonen MK, Ollila S, Nyström M, Gerdes AM, Kariola R.

Fam Cancer. 2011 Sep;10(3):515-20. doi: 10.1007/s10689-011-9436-z.

PMID:
21431882
8.

Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).

Lynch HT, Lynch JF, Lynch PM.

J Natl Cancer Inst. 2007 Feb 21;99(4):261-3. No abstract available.

PMID:
17312298
9.

Performance of Lynch syndrome predictive models in a multi-center US referral population.

Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, Kupfer SS, Terdiman J.

Am J Gastroenterol. 2011 Oct;106(10):1822-7; quiz 1828. doi: 10.1038/ajg.2011.200. Epub 2011 Jul 12.

10.

Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations.

Hu P, Lee CW, Xu JP, Simien C, Fan CL, Tam M, Ramagli L, Brown BW, Lynch P, Frazier ML, Siciliano MJ, Coolbaugh-Murphy M.

Ann Clin Lab Sci. 2011 Fall;41(4):321-30.

PMID:
22166501
11.

BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.

Nieminen TT, Abdel-Rahman WM, Ristimäki A, Lappalainen M, Lahermo P, Mecklin JP, Järvinen HJ, Peltomäki P.

Gastroenterology. 2011 Jul;141(1):e23-6. doi: 10.1053/j.gastro.2011.03.063. Epub 2011 Jun 1. No abstract available.

PMID:
21640116
12.

Prospective immunohistochemical analysis of primary colorectal cancers for loss of mismatch repair protein expression.

Lee-Kong SA, Markowitz AJ, Glogowski E, Papadopoulos C, Stadler Z, Weiser MR, Temple LK, Guillem JG.

Clin Colorectal Cancer. 2010 Oct;9(4):255-9. doi: 10.3816/CCC.2010.n.038.

PMID:
20920999
13.

Making sense of missense in Lynch syndrome: the clinical perspective.

Lynch HT, Jascur T, Lanspa S, Boland CR.

Cancer Prev Res (Phila). 2010 Nov;3(11):1371-4. doi: 10.1158/1940-6207.CAPR-10-0204. Epub 2010 Oct 26.

14.

Classification of mismatch repair gene missense variants with PON-MMR.

Ali H, Olatubosun A, Vihinen M.

Hum Mutat. 2012 Apr;33(4):642-50. doi: 10.1002/humu.22038.

PMID:
22290698
15.

Mismatch repair genes in Lynch syndrome: a review.

Silva FC, Valentin MD, Ferreira Fde O, Carraro DM, Rossi BM.

Sao Paulo Med J. 2009 Jan;127(1):46-51. Review.

16.

8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome.

Talseth-Palmer BA, Scott RJ, Vasen HF, Wijnen JT.

Eur J Hum Genet. 2012 May;20(5):487-8; author reply 488. doi: 10.1038/ejhg.2011.232. Epub 2011 Dec 14. No abstract available.

17.

Lynch syndrome in colorectal cancer patients.

Giráldez MD, Castellví-Bel S, Balaguer F, Gonzalo V, Ocaña T, Castells A.

Expert Rev Anticancer Ther. 2008 Apr;8(4):573-83. doi: 10.1586/14737140.8.4.573. Review.

PMID:
18402524
18.

Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil.

Cossio SL, Koehler-Santos P, Pessini SA, Mónego H, Edelweiss MI, Meurer L, Errami A, Coffa J, Bock H, Saraiva-Pereira ML, Ashton-Prolla P, Prolla JC.

Fam Cancer. 2010 Jun;9(2):131-9. doi: 10.1007/s10689-009-9297-x.

PMID:
19821155
19.

Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions.

Martinez SL, Kolodner RD.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5070-5. doi: 10.1073/pnas.1000798107. Epub 2010 Feb 22.

20.

Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.

Pande M, Wei C, Chen J, Amos CI, Lynch PM, Lu KH, Lucio LA, Boyd-Rogers SG, Bannon SA, Mork ME, Frazier ML.

Fam Cancer. 2012 Sep;11(3):441-7. doi: 10.1007/s10689-012-9534-6.

Supplemental Content

Support Center